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Circular dichroismStructural studies of membrane protein are still challenging due to several severe bottlenecks, the ﬁrst being
the overproduction of well-folded proteins. Several expression systems are often explored in parallel to fulﬁl
this task, or alternately prokaryotic analogues are considered. Although, mitochondrial carriers play key roles
in several metabolic pathways, only the structure of the ADP/ATP carrier puriﬁed from bovine heart mito-
chondria was determined so far. More generally, characterisations at the molecular level are restricted to
ADP/ATP carrier or the uncoupling protein UCP1, another member of the mitochondrial carrier family,
which is abundant in brown adipose tissues. Indeed, mitochondrial carriers have no prokaryotic homologues
and very few efﬁcient expression systems were described so far for these proteins. We succeeded in produc-
ing UCP1 using a cell free expression system based on E. coli extracts, in quantities that are compatible with
structural approaches. The protein was synthesised in the presence of a ﬂuorinated surfactant, which main-
tains the protein in a soluble form. Further biochemical and biophysical analysis such as size exclusion chro-
matography, circular dichroism and thermal stability, of the puriﬁed protein showed that the protein is non-
aggregated, monodisperse and well-folded.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
UCP1 (uncoupling protein 1) belongs to the mitochondrial carri-
er family (MCF), which comprises more than 40 integral membrane
proteins transporting metabolites across the inner mitochondrial
membrane [1]. This transport is linked to major metabolic path-
ways occurring in mitochondria, which are essential to eukaryotic
metabolism. Because of their functional importance, impairment
of such carriers leads to severe diseases (for review see [2]). MCF
members share several characteristics: (a) they are encoded by nuclear
genes, (b) they have a molecular mass of 30–35 kDa, (c) six trans-
membrane helices are predicted from their sequence, (d) their se-
quence displays three repeated regions of about 100 amino acidsochondrial carrier family; AAC,
cal micellar concentration; CD,
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l rights reserved.each, and (e) strongly conserved amino acids forming a character-
istic signature for these carriers, the MCF motif, are found in each
repeated region. Despite of these common features each of them
is highly speciﬁc to the transport of one metabolite [3]. The ADP/
ATP carrier (AAC) is the most studied MCF carrier and is the ﬁrst
for which a high-resolution structure was solved [4]. From the loca-
tion of MCF motifs in the structure, it is predicted that all MCF
members have a similar folding. However, the speciﬁc recognition
mode of the substrates as well as the conformation changes occur-
ring during the transport, still are elusive. UCP1 is the second most
studied MCF member (for review see [5]). By inducing a proton leak
across the inner mitochondrial membrane, it is responsible for the dis-
sipation of the proton gradient [6,7], and the uncoupling of oxidative
phosphorylation from ATP synthesis. UCP1 is expressed in the brown
adipose tissue (BAT) and because of the respiration uncoupling, fat
stored into brown adipocytes converts into heat. UCP1 is a key compo-
nent of non-shivering thermogenesis and several reports suggest its
role in the protection against diet-induced obesity [8–10].
All the efforts to characterise biochemically and structurally MCF
carriers are hindered by the difﬁculty in producing sufﬁcient amounts
of high-quality samples, known to be a major bottleneck for
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carriers consist in 6 transmembrane helices partially interacting with
the lipid bilayer and partially accessible to the solvent, explaining
their high lability. This topology was conﬁrmed with the recent
UCP2 structure [11]. Most of the published studies on puriﬁed MCF
carriers have been made with protein puriﬁed from native tissues,
which explains the more extensive studies on AAC extracted from
heart or liver mitochondria (see i.e. [12–14] and for review [15]),
and on UCP1 found in BAT (see i.e. [16–19], and for review [20]). Al-
though AAC and UCP1 are quite abundant in heart or liver mitochon-
dria and BAT, respectively, the puriﬁcation of native proteins
remains difﬁcult to control and the production of mutants necessary
for the study of structure–function relationships impossible. One of
the major biochemical difﬁculties is that native MCF do not bind to
chromatographic column and instead are generally isolated from the
ﬂow through of hydroxylapatite column when solubilised with Triton
X-100 or LAPAO. A bacterial expression protocol including a large
number of steps was recently published for UCP2 and led to the ﬁrst
structural insights of UCP2 by NMR [11]. Establishing efﬁcient and ro-
bust protocols for the heterologous production and puriﬁcation of
functional mitochondrial carriers still remains an essential but chal-
lenging task for the study of the MCFs.
Two heterologous production systems of UCP1 have been de-
scribed so far: (a) the production in E. coli as inclusion bodies
[21–23] and (b) the expression in yeast [24–27]. Although, the oxo-
glutarate/malate carrier has been produced in large amounts from in-
clusion bodies [28], UCP1 could not be produced with similar yields.
The ﬁnal amounts of pure protein obtained from inclusion bodies orF
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Fig. 1. Chemical structures of FTACs, CnUm and Tripod surfactants. FTACs are short oligomers
rinated mercaptans as transfer reagents, to introduce (hemi) ﬂuorinated chain at the end o
terial which is ﬁrst endowed with two hydrophobic tails bearing Cn carbon atoms, then in
moieties (m) as polar heads [34]. Three hydrocarbon chains and three glucosyl groups are
C5Glu3, respectively [35].yeast are low and rather inadequate for structural studies. We present
herein the production of UCP1 using the cell free system, which cou-
ples transcription and translation reactions into the same reaction
medium [29]. This technique developed since a decade mainly for sol-
uble proteins, emerged recently for membrane proteins. A consider-
able variety of prokaryotic or eukaryotic membrane proteins,
belonging to different family, having up to twelve membrane helices
and for some with molecular masses exceeding 100 kDa, have already
been successfully expressed (for review see [30]). Among other ad-
vantages, cell free expression overcomes general limitations known
for cellular expression such as targeting, translocation and insertion
into the cell membrane, a limited volume of membranes into which
proteins can be inserted, and toxic or inhibitory effects induced by
the proteins on the host cell. In addition, the set-up of the cell free
system offers a multitude of options to adapt the reaction conditions
and to directly supply any compound favouring the expression or sta-
bility of proteins of interest. In order to produce UCP1 in the soluble
fraction of the reaction medium, we added surfactants above their
critical micellar concentrations (cmc) and explored various types of
compounds from classical detergents to non commercial surfactants.
Fluorinated surfactants [31] are of particular interest for stabilising
membrane proteins [32] and were already shown to be compatible
with the cell free machinery [33]. We were able to produce UCP1 in
quantities that are compatible with structural studies in the presence
of ﬂuorinated surfactants. As shown from size exclusion chromatog-
raphy and circular dichroism, including thermal stability, the protein
is monodisperse, well-folded and sufﬁciently stable for structural
studies.R-HNCO
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of Tris (hydroxymethyl) acrylamidomethane (THAM) prepared in the presence of ﬂuo-
f polymeric backbone [31]. CnUm are prepared from mercapto glycerol as starting ma-
volved in telomerization reaction of THAM monomer to multiply the number of Tris
grafted onto the central mesitylene forming the hydrophobic and hydrophilic faces of
Table 2
Effect of additives on rUCP1 solubility. Solubility of the protein synthesised in the pres-
ence of (A) 4 mM FTAC and different additives or (B) different surfactants in the pres-
ence of 0.28 mM cardiolipin. The solubility was evaluated on the same scale as for
Table 1. The surfactant and additives concentration used are given in the brackets.
Some additives inhibited the synthesis. When scaled up to a 1 mL reaction mixture,
in the presence of F8TAC5 and cardiolipins the quantity of protein is estimated to
about 1 mg with 90% in the supernatant and 10% in the pellet.
A.
Additives Solubility
No additive 6
E. coli lipids (0.4 g/L) 6
Cardiolipin (0.28 mM=0.4 g/L) 9
Facial amphiphile C5Glu3 (0.25 mM) 6
Peptergent KA6 (0.1 mM) 6
Lauric acid (0.1 mM) No synthesis
GDP (0.1 mM) No synthesis
B.
Surfactant UCP1 solubility
No additive Cardiolipin
F8TAC5 (4 mM) 6 9
C13U19 (0.8 mM) 6 4
DDM (1.7 mM) 3 1
Brij35 (3.3 mM) 5 9
Brij58 (0.9 mM) 5 0
Digitonin (32.2 mM) 5 5
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2.1. Surfactants and lipids
Detergents were purchased from Anatrace (except Triton X-100
from Sigma), and lipids from Avanti Polar Lipids. Hemiﬂuorinated
(HFTACs) or ﬂuorinated surfactants (FTACs), phospholipid-like sur-
factants (CnUm) and facial amphiphiles C5Glu3 (Fig. 1), were synthe-
sised by one coauthoring team (B. Pucci, A. Polidori and L.A. Barret).
FnTACm contain ﬂuorinated hydrophobic tails consisting of n carbons
(6 or 8 in this study), and m is the average degree of polymerization
of the polar head [31]. Their physical–chemical properties (including
cmc) are independent of the average degree of polymerization of the
polar head. Three different FTACs were initially screened (Table 1).
Only F8TAC5 was considered in additive screens and upscale experi-
ments. In the corresponding sections, unless speciﬁed, FTAC refers
to F8TAC5. Phospholipid-like surfactants CnUm have two hydrophobic
tails bearing Cn carbon atoms, and m Tris moieties as polar heads [34].
The hydrophobic face of the facial amphiphile C5Glu3 consists of three
short hydrocarbon chains (3 to 7 carbons each). Three glucosyl
groups grafted onto a central mesitylene constitute the hydrophilic
face [35]. The peptergents were a gift from S. Zhang (MIT, USA).
2.2. Cloning
The rUCP1 cDNAwas ampliﬁed by PCR using the primers UCP1-NOTI-
FW (TATGAGCGGCCGCATGGTGAGTTCGACAACTTCCG) and UCP1-CFR9I-
24A-REV (CGGATCCCGGGCTATGTGGTGCAGTCCACTGTCTGC) for inser-
tion into the plasmid pIVEX 2.4a (Roche) or UCP1-CFR9I-MCS-REV
(CGGATCCCGGGTGTGGTGCAGTCCACTGTCTGCC) for insertion into the
plasmid pIVEX 2.3MCS (Roche). The PCR product was inserted between
the NotI and Cfr9I restrictions sites of the vectors pIVEX 2.4a or pIVEX
2.3MCS encoding for anN-terminal or C-terminal poly (His) 6 tag respec-
tively. These vectors are optimised for expression in theRapid Translation
System (RTS) cell-free system used in this study. Constructs were
checked by sequencing.
2.3. Cell free expression
Cell free expression experiments were performed using the Roche
E. coli RTS system according to the manufacturer's instructions. ForTable 1
Effect of surfactants on rUCP1 solubility. For each surfactant the table indicates its charge, cmc
scale from 0 to 10, 5 corresponding to half of the protein in the supernatant and 10 correspond
Z: zwitterionic.
Surfactant type Surfactant Charge
Glucosides DDM N
Cymal 5 N
Polyethylene glycols Triton X-100 N
Polyoxyethylenes C10E5 N
Brij35 N
Brij58 N
Steroids Digitonin N
Amine oxides LDAO Z
LAPAO Z
Lipid like detergents FC12 Z
FC14 Z
FC16 Z
Phospholipid like surfactants C13U19 N
C15U25 N
C17U16 N
Fluorinated compounds HFTAC N
F6TAC10 N
F6TAC5 N
F8TAC5 N
Facial amphiphiles C5Glu3 Nsmall scale (batch) production, 0.5 μg of plasmid DNA was incubated
for 24 h, at temperatures ranging from 15 °C to 28 °C in the RTS 100
HY kit reaction mixture (ﬁnal volume of 25 μL). The synthesis was fol-
lowed by a centrifugation step at 18,000 g for 15 min (4 °C). The su-
pernatant and the pellet resuspended in 50 mM Tris buffer, pH 7.5
were subsequently analysed by SDS-PAGE, Western blotting and
immunodetection of the (His) 6-tag. The production of soluble pro-
tein was achieved by supplying into the reaction mixture different
surfactants and additives listed in Tables 1 and 2.
For preparative experiments, 10 μg of plasmid DNA was incubated
in the RTS 500 ProteoMaster HY lysate supplemented with 4 mM
FTAC and 0.28 mM cardiolipin in a ﬁnal volume of 1 mL. After 24 h in-
cubation at 28 °C the reaction mixture was centrifuged 15 min at
18,000 g (4 °C) and the supernatant was used for the puriﬁcation of
the protein., the concentration used (mM) and the result obtained. The solubility was evaluated on a
ing to the detection of the protein exclusively in the supernatant. N: non ionic, A: anionic,
cmc (mM) Concentration (mM) UCP1 solubility
0.17 0.85 3
2.4 24 2
0.23 2.3 0
0.81 8.1 0
0.091 3.3 5
0.004 0.9 5
0.5 6.5 5
1.00 10 No synthesis
1.56 15.6 No synthesis
1.5 15 No synthesis
0.12 1.2 No synthesis
0.013 0.13 3
0.008 0.08 6
0.0055 0.055 6
0.005 0.05 6
0.45 9 6
0.3 7.5 6
0.3 7.5 6
0.03 0.75 6
0.12 1.23 0
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rUCP1 was puriﬁed by afﬁnity chromatography using a Ni-NTA
resin. The supernatant recovered from the large scale synthesis was
diluted ten times in 50 mM Hepes, pH 7.5, 200 mM NaCl containing
10 mM imidazole and incubated with 250 μL of preequilibrated
resin (Ni-NTA Superﬂow, Qiagen). After 1 h incubation at 4 °C,
under shaking, the suspension was poured into a column and exten-
sively washed with buffer A (50 mM Hepes, pH 7, 200 mM NaCl,
0.014 mM cardiolipin, 0.15 mM FTAC) and increasing concentrations
of imidazole (10, 20 and 40 mM). The protein was eluted at
200 mM imidazole.
2.5. Size-exclusion chromatography
The apparent molecular mass and the Stokes radius of the rUCP1-
surfactant complex (Rs) were analysed by size-exclusion chromatogra-
phy using a Superdex 200 10/300 GL column (GE Healthcare). Standard
proteins (ferritin, aldolase, ovalbumin, and ribonuclease; Bio-Rad)were
used to calibrate the column with the same buffer. Prior to the size-
exclusion analysis, imidazole was removed by dialysis and during con-
centration in Amicon Ultracel-30k concentrator (Millipore).
2.6. UCP1 puriﬁed from BAT
The puriﬁcation procedure was described by Lin and Klingenberg
[36]. Brieﬂy, brown adipose tissue (BAT) mitochondria were isolated
from one week cold-adapted mice. Mitochondria were cleaned up
with 3.2% lubrol in buffer 20 mM MOPS pH 6.8, 20 mM Na2SO4,
1 mM EDTA. The proteins were then solubilised 30 min in 2% C10E5.
UCP1 was puriﬁed on hydroxyapatite column previously washed
with buffer containing 0.05% C10E5. The buffer was then exchanged
for 10 mM KPi pH 6.5 by desalting on a HiTrap 5 mL column.Fig. 2. Cell free production of rUCP1. (A) In the absence of surfactants. (B) In the presence
without any additives, 2 — with 1 mM A6K-NH2 (peptergent), and 3 — with 0.28 mM cardi
surfactants were used at the concentration described in Table 1. The notations used are as2.7. Circular dichroism spectroscopy
Prior to the circular dichroism experiments on cell-free expressed
rUCP1, the buffer composition of the protein solution was changed to
25 mM KPi pH 7, 0.014 mM cardiolipin, 200 mM NaF (supplemented
with 0.15 mM FTAC) by dialysis and during concentration in Amicon
Ultracel-30k concentrator (Millipore). The measurements were per-
formed using a Peltier temperature controlled spectropolarimeter
(JASCO model J-810) equipped with a 0.1 cm path length cell. The
CD spectrum of native UCP1, was recorded on a Jasco Model J-815
using a 0.1 cm path length cell. For both proteins, ten scans were col-
lected at 20 °C from 260 to 200 nm at 0.5 nm intervals, then averaged
and baseline-corrected by subtraction of blank buffer. After subtract-
ing the blank signal, the CD signal (in millidegrees) was converted to
mean molar residue ellipticity (in deg.cm2.dmol−1). Thermal dena-
turation of cell-free expressed rUCP1 was followed by continuously
monitoring ellipticity changes at a ﬁxed wavelength (220 nm) while
the sample was heated up at a constant rate from 20 °C to 90 °C. Spec-
tra were analysed with the Spectra Manager II software (Jasco) in-
cluding the protein secondary structure determination.
3. Results
3.1. Small-scale cell free production of rUCP1
First, the expression of the two rUCP1 constructs (His-rUCP1 and
rUCP1-His) was determined in detergent free batch reactions using
RTS 100 kits. Interestingly, only His-rUCP1 was synthesised in detect-
able amounts. The inﬂuence of the position of the tag on the amount
of proteins produced with the cell free system was already reported
in a study of Pseudomonas aeruginosa proteins [37]. Although there
is no general rule for the position of tag, the location of the His-tag
in its N-terminus is important for an optimal synthesis of rUCP1.of different surfactants. (C) In the presence of 4 mM FTAC and different additives: 1 —
olipin. The protein was synthesised as described in Material and methods section. The
follows: Triton, Triton X-100; P, pellet; S, supernatant.
Fig. 3. Puriﬁcation of rUCP1 as analysed by SDS-PAGE. rUCP1 was puriﬁed as described
in the Material and methods section; Lane 1, supernatant of the reaction mixture be-
fore puriﬁcation; Lane 2, protein eluted from the Ni-NTA resin. Protein standards in
kDa are indicated on the left side.
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ments. After the synthesis reaction of His-rUCP1, the supernatant
and the pellet were separated by centrifugation and analysed by
Western blots. As expected for a membrane protein, rUCP1 was
detected exclusively in the pellet (Fig. 2A).
Three different strategies, commonly used for the cell free produc-
tion of membrane proteins (for review see [30]) were then initially
explored: (a) the production of the protein as a precipitate and the
subsequent solubilisation of the pellet by detergents, (b) the synthe-
sis of the protein in the presence of liposomes and (c) the synthesis of
the protein in the presence of surfactants. While preliminary experi-
ments following the ﬁrst two strategies failed to produce soluble
rUCP1, the cell free production of the protein in presence of surfac-
tants proved to be efﬁcient and was further explored.
3.2. rUCP1 cell free production in the presence of surfactants
To identify the ideal surfactant that results in the production of
completely solubilised proteins while maintaining high expression
levels, a panel of different types of surfactants was tested (see
Table 1 and Fig. 2B). The panel not only contained classical detergents
but also other amphiphilic molecules, which are able to surround
membrane proteins and to maintain them in solution (Fig. 1). Some
of them were already shown to be compatible with the cell free pro-
duction of other membrane proteins, like DDM [38–40], Triton X-100
[39,41], Brij35 or Brij58 [39], digitonin [39,42] and ﬂuorinated com-
pounds [43]. LAPAO and C10E5 were never used in cell free protein
production but are known to be efﬁcient for the solubilisation of mi-
tochondrial carriers [12,44,45]. The use of facial amphiphiles and
phospholipid-like surfactants (CnUm) in a cell free expression system
was also never reported.
In order to provide the appropriate environment necessary to
maintain a membrane protein in solution, all the surfactants were test-
ed at concentrations above their cmc, as speciﬁed in Table 1. In each
case, the solubility of the protein was ranked according to the propor-
tion of the protein present in the supernatant versus pellet, on a scale
from 0 (all the protein in the pellet) to 10 (all the protein in the super-
natant). Three categories of surfactants could be deﬁned: (a) inhibitors
for the synthesis reaction, (b) not capable to produce soluble rUCP1
and (c) capable to produce at least partially soluble rUCP1.
Most of the zwitterionic surfactants (LDAO, LAPAO, FC12, FC14)
were inhibitory for the synthesis reaction at the used concentrations,
except FC16, which even increased the level of soluble protein. All the
fos-cholines were used at ten times their cmc. Given the low cmc of
FC16, the concentration used for FC16 was signiﬁcantly lower than
for FC12 and FC14, which probably explain its lack of toxicity. Indeed,
increasing ten times the FC16 concentration proved to be also inhibi-
tory for the cell free reaction (data not shown). The capacity of fos-
cholines to inhibit the cell free synthesis of protein when used at
high concentration was already described by Kaiser et al. [42].
Triton X-100, a non ionic surfactant widely used for the puriﬁca-
tion of MCFs from native tissues, was compatible with the in vitro syn-
thesis but surprisingly not efﬁcient for the production of soluble
protein (Fig. 2B). Same result was obtained with the facial amphiphile
C5Glu3. Maltosides (DDM and Cymal5) only partially maintained the
protein in solution. Among polyoxyethylenes, C10E5 was not able to
produce soluble proteins, but about 50% of the proteins was obtained
in the soluble fraction in the presence of dodecyl or hexadecyl poly-
oxyethylenes analogues like Brij35 and Brij58. Even surfactants with
similar chemical nature displayed different effects and similar devia-
tions were already reported for the cell free synthesis of GPCRs [46].
From all these data, it is not obvious whether a longer hydrophobic
tail or polydispersity of the surfactant favours the production of solu-
ble protein. Good results were also obtained with the steroidian de-
tergent, digitonin (about half of the protein was soluble). The best
yields for the production of soluble rUCP1 were obtained with lesscommonly used surfactants like phospholipid-like surfactants
(CnUm) [34] and ﬂuorinated surfactants (FTACs). About 60% of the
protein was detected in the supernatant in the presence of the six
ﬂuorinated surfactants and the three CnUm tested independently of
the length of the ﬂuorinated or hydrocarbon chains.
However, among all the surfactants tested, none of them was able
to produce 100% of the protein in the soluble fraction. Increasing the
DDM, CnUm and FTAC concentrations did not enhance the fraction of
soluble protein and even reduced it for DDM (results not shown).
Varying the temperature of the synthesis reaction to 15 °C, 20 °C or
28 °C did not improve the proportion of soluble protein and even sig-
niﬁcantly reduced the total amount of protein at 15 °C (results not
shown). We therefore investigated the effect of additives.
3.3. Effect of additives on rUCP1 solubility
Awide range of additives was systematically tested to enhance the
solubility of protein produced in presence of FTAC (Table 2A and
Fig. 2C). They were chosen based on their stabilising effect reported
on other membrane proteins (peptergents [47] or lipids) or on their
functional effect on UCP1 (lauric acid or GDP known to activate or in-
hibit UCP1, respectively [48,49]). Peptergents or E. coli lipids did not
increase the soluble fraction of the protein. Activators, like lauric
acid, or inhibitors, like GDP, could favour a single conformation and
thus prevent ﬂexibility due to conformational disorder. However,
adding lauric acid or GDP inhibited the synthesis reaction. Most inter-
estingly, in the presence of cardiolipins almost all the protein was
detected in the supernatant. Cardiolipins were then added in combi-
nation with surfactants other than FTAC like C13U19, Brij35, Brij58,
digitonin and DDM (Table 2B). Surprisingly, the cardiolipin effect
was very different depending on the surfactant. The soluble fraction
of the protein was improved in the presence of Brij35 while no effect
was observed with digitonin. The solubility of the protein was even
decreased when cardiolipin was added to Brij58, DDM or C13U19.
3.4. Preparative scale expression of rUCP1 and puriﬁcation
The production was scaled up using the RTS 500 system and the
best conditions determined with the batch experiments were ﬁrst
tested. The synthesis was carried out (a) in the presence of 4 mM
FTAC and 0.28 mM cardiolipin or (b) in the presence of 3.3 mM
Brij35 and 0.28 mM cardiolipin. Then, the reaction mixture was cen-
trifuged and rUCP1 was mainly detected in the supernatant for both
of these conditions. The protein was puriﬁed in a one step afﬁnity pu-
riﬁcation on Ni-NTA resin. Preliminary tests revealed that the yield
could be easily improved when working with FTAC. Therefore, further
Fig. 4. Size exclusion chromatography analysis of puriﬁed rUCP1. Puriﬁed rUCP1 in the
presence of FTAC was applied to a Superdex 200 HR 10/30 column. The column was
equilibrated with 25 mM Hepes, pH 7, 200 mM NaCl supplemented with 0.15 mM
FTAC and 0.014 mM cardiolipin. Fractions of 0.5 mL were collected starting from
0 mL. Western blots with anti His-tag immunodetection of the protein present in var-
ious elution fractions are shown in the insets. V0 is the void volume.
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and cardiolipin. Most impurities were washed off with sequential
washing steps at 10, 20 and 40 mM imidazole and the bound protein
eluted with 200 mM imidazole. The purity of the eluted protein was
analysed on a Coomassie blue stained SDS-PAGE gel (Fig. 3). Except
the band corresponding to the expected mass of rUCP1, one band at
about 75 kDa and several bands at lower molecular masses could be
noticed. Lower molecular mass bands could correspond to not fully
synthesised proteins, a common problem encountered in cell free ex-
pression. Indeed, all the fragments that contain the N-terminal His-
tag are recovered after Ni-NTA puriﬁcation. The yield of puriﬁed pro-
tein ranged from 0.6 to 0.8 mg per mL of reaction mixture. This
amount is quite high and compatible with structural studies. Further-
more, the method from expression to puriﬁcation is very simple and
fast as compared to the production from inclusion bodies.
3.5. Size exclusion chromatography
The protein was subjected to size exclusion chromatography in
order to investigate the dispersity and homogeneity of the sample.Fig. 5. Circular dichroism spectroscopy of puriﬁed UCP1. (A) CD spectra of the cell-free expre
The data were recorded at 20 °C in a 0.1 cm path length cell. Ten scans were collected at 0.5
of blank buffer. (B) Melting curve of cell-free produced rUCP1 puriﬁed in the presence of FWe analysed the Stokes' radii and the apparent molecular mass of
the rUCP1-surfactant-lipid complex in the presence of FTAC (Fig. 4).
The size-exclusion elution proﬁle of rUCP1 contained two main
peaks with an elution volume of 12.35 mL and 14 mL, respectively
(Fig. 4). A small shoulder at higher molecular mass (elution volume
9.7 mL) was also observed. The Western blot analysis showed that
the ﬁrst peak was essentially composed of full-length rUCP1 while
the second contained only fragments of not fully synthesised protein.
Of note, fragments of rUCP1 were efﬁciently separated from the full-
length protein by this additional SEC puriﬁcation step, therefore use-
ful to improve the purity of the sample. After removal of the second
peak, rUCP1 was monodisperse and eluted with an apparent molecu-
lar mass of 179 kDa. Using a calibration curve, a Stokes radius of
4.6 nm was determined for the protein-surfactant-lipid complex. No
signiﬁcant peak corresponding to the void volume was evidenced in
the size exclusion proﬁle, showing that the protein did not aggregate.
3.6. Circular dichroism
To further investigate the in vitro synthesised protein after puriﬁ-
cation, its secondary structure was analysed by CD spectroscopy. As
shown in Fig. 5A, the far-UV CD spectra of rUCP1 puriﬁed in FTAC in
the presence of cardiolipin exhibited two negative maxima near
222 nm and 208 nm indicating a signiﬁcant α-helix content in the
secondary structure. Comparison of the spectra obtained in the ab-
sence or in the presence of 100 μM GTP did not indicate any signiﬁ-
cant differences at the level of the secondary-structure (data not
shown). Thermal denaturation of rUCP1 was also investigated by CD
by continuous recording of ellipticity at 220 nm while heating up
the sample from 20 °C to 90 °C (Fig. 5C). The Tm value measured for
the protein puriﬁed in FTAC was 64 °C.
4. Discussion
The cell free system has become over the last few years an interest-
ing alternative for the production of membrane proteins (for review,
see [30]). Cell free synthesised human VDAC could even be crystal-
lised, thus demonstrating the structural homogeneity of the protein
[40]. Fluorinated surfactants were successfully used to stabilise mem-
brane proteins (see i.e. [50]) and proved to be efﬁcient for the cell free
synthesis of bacterial proteins [33]. As mitochondrial carriers are par-
ticularly labile eukaryotic proteins, cell free synthesis in the presence
of ﬂuorinated compounds or other amphiphiles was therefore ex-
plored herein. The best results for producing a large soluble fraction
of rUCP1 were obtained with phospholipid-like surfactants (CnUm)ssed rUCP1 puriﬁed in the presence of FTAC (black line) and of native UCP1 (grey line).
nm intervals from 260 to 200 nm, then averaged and baseline-corrected by subtraction
TAC.
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as additives, the solubility of rUCP1 synthesised in FTACs and also
Brij35 was highly enhanced. The use of Brij35 in a cell free system
was already described [30], while the use of CnUm is novel. CnUm are
water-soluble non-ionic surfactants. They display interesting low de-
naturing properties and have stabilising capacities. Endowed with
two hydrophobic tails, they mimic natural phospholipids and are sug-
gested to associate with membrane proteins and maintain them solu-
ble in aqueous solution without prohibitive unfolding [34]. The use of
FTACswas earlier explored for the stabilisation of membrane proteins.
Bacteriorhodopsin and cytochrome b6f have been shown to be more
stable once transferred to FTACs than in the presence of detergents
[32]. A similar effect was shown on Smoothened, a human G-protein
coupled receptor [51]. Fluorinated surfactants are highly hydrophobic
but also lipophobic. Using dye-labelled FTACs, it could be demonstrat-
ed by ﬂuorescence correlation spectroscopy that these molecules do
not interact with lipids [52]. In contrast to detergents, FTACs do not
competewith protein–lipid, but most probably also with protein–pro-
tein or intra-protein interactions. In combination to the relative stiff-
ness of their chains compared to detergents, these properties are
favourable to the maintenance of membrane protein integrity and
function. For example, speciﬁc ATPase activity of the yeast F1–F0
ATP-synthase was reported to be higher in FTAC than in DDM, and in
addition, the sensitivity towards inhibitors remained strong even
after 6 weeks [50]. Fluorinated surfactants were also described as pos-
sible chemical chaperones as inferred from their efﬁciency in forming
themembrane-competent form of diphtheria toxin T-domain by acid-
iﬁcation [52]. When synthesising rUCP1 in the cell free system, this
chaperone property could explain the higher yield of soluble protein
observed in the presence of FTAC. FTACs were already used with suc-
cess for the cell free production of a bacterial mechanosensitive ion
channel MscL [43]. Here, we demonstrate that FTAC is also a valuable
surfactant for expressing a labile mammalian membrane protein.
Cardiolipin is highly abundant in the inner mitochondrial mem-
brane. Being a dimer of phosphatidylglycerol, it contains two polar
heads and four aliphatic chains instead of two as for most of the phos-
pholipids. Several studies showed that cardiolipins play an important
role for the structural integrity of mitochondrial carriers [53,54]. The
high resolution structures of AAC revealed three cardiolipins that sur-
round the carrier and that are tightly bound through several interac-
tions [53,4]. The phosphate groups of the three lipid molecules mainly
interact with main chain nitrogens of AAC, while their acyl chains
stack to aromatic residues located in MCF motifs. The ﬁrst type of in-
teraction is related to the overall fold of MCF carriers, and the second
to residues conserved in MCF motifs. Therefore both types of interac-
tions are not speciﬁc to AAC and possibly exist in other MCF carriers.
In particular in UCPs, the increase in the solubility of the cell free pro-
duced rUCP1 could be explained by a stabilising effect by cardiolipins.
Because FTACS are poorly miscible with lipids, they do not perturb
putative interactions between rUCP1 and cardiolipins in contrast to
detergents as for example DDM. A similar effect was observed for
the yeast F1–F0 ATP-synthase. Relipidation of this complex in DDM
did not rescue its speciﬁc ATPase activity nor its sensitivity to inhibi-
tors. In contrast, in FTAC both properties were maintained for more
than 40 days after extraction [50].
Although no functional assays have been developed so far on
rUCP1 produced in the cell free system, the protein was characterised
by several means. The Stock radius of 4.6 nm and the apparent molec-
ular mass of 179 kDa measured from size exclusion chromatography,
were consistent with data reported for the ADP/ATP carrier, predicted
to have a similar overall shape as UCP1. Indeed, in the presence of
various detergents having hydrophobic chains of similar length to
FTAC (such as C12M, C13M or LAPAO), Rs values for AAC-detergent
complex were determined in the range of 4 to 4.5 nm by two groups
[55,56]. In both studies, AAC was shown to be monomeric. The Rs
value of 4.6 nm would be therefore consistent with a monomericrUCP1 in FTAC. Our CD spectra are comparable with those previously
reported for UCP1 puriﬁed from inclusion bodies [23] and from yeast
[57] but also with the CD spectrum recorded for native UCP1 puriﬁed
from BAT (Fig. 5A), suggesting that the secondary structures are sim-
ilar. Indeed, similarly to [57], the shape between 200 and 240 nm is
characterised by two negative peaks located at 208 and 222 nm. In
addition, the addition of GDP does not modify signiﬁcantly the sec-
ondary structure of the protein as reported in [57]. Overall, CD ana-
lyses showed that rUCP1 produced in the cell free system in the
presence of FTAC is folded mainly as α-helices as expected. We esti-
mate that 60% of cell-free expressed UCP1 is α-helical. From their
CD data, Douette et al. evaluated the α-helical structure to 68%
while Jelokhani-Niaraki et al. reported 40 to 50%. In addition, the
known structures of members of the same MCF family, bAAC1 [4]
and mUCP2 [11] highlight 67% (55% in the TM helices and 12% within
the structured part of the matrix loops) for both bAAC1 and mUCP2.
Our data are consistent with all these values, considering structural
variability of matrix loops (they vary depending on the conformation-
al state of the carriers) and also lack of accuracy of the value calculat-
ed herein due to the missing part below 200 nm. Finally, thermal
denaturation over 60 °C is a good indication of a well-deﬁned tertiary
structure below Tm. In comparison with other membrane proteins
that were successfully puriﬁed in the presence of FTAC and functional,
we anticipate that rUCP1 produced in the cell free system in the pres-
ence of FTAC is adequate for structure–function studies.
5. Conclusion
We demonstrate herein that rUCP1 can be produced in a cell free
system in the presence of a ﬂuorinated surfactant FTAC. This is the
ﬁrst example of the use of ﬂuorinated surfactants for producing
large quantities of eukaryotic membrane proteins in the cell free sys-
tem. This method is fast and simple compared to the production from
inclusion bodies. It is also ﬂexible and constitutes a valuable alterna-
tive to the expression of MCF carriers. The protein forms monodis-
perse protein-surfactant complexes whose size is compatible with a
monomeric state. The protein is mainly structured in α-helices and
the amounts obtained after puriﬁcation are compatible with structur-
al studies.
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